Please select the outcome measures that correspond to the clinical trial below.
Title: Long-term Effectiveness of Abdominal Sacrocolpopexy for the Treatment of Pelvic Organ Prolapse: The Extended Colpopexy and Urinary Reduction Efforts (E-CARE) Study
Brief Summary: The Colpopexy and Urinary Reduction Effort (CARE) trial is a research study designed to evaluate whether the addition of a second surgical procedure in addition to a procedure for female pelvic organ prolapse (POP) affects the rates of urinary incontinence. This study will follow women in the CARE study for 10 years from the time of the surgery to compare success and complication rates in the two groups. Recruitment into this study is open only to women that already participated in CARE. Recruitment into CARE is closed.


Options:
A: anatomic outcomes,graft-related complications between the two materials, changes in pelvic organ prolapse-related quality of life,subjective changes in sexual function,changes in bowel function and the prolapse related pain present after sacral colpopexy (One year)
B: Number of Participants With Symptomatic Failure (24 months); Number of Participants With Symptomatic Failure (3 year); Number of Participants With Symptomatic Failure (4 year); Number of Participants With Symptomatic Failure (5 year); Number of Participants With Symptomatic Failure (6 year); Number of Participants With Symptomatic Failure (7 year); Number of Participants With Anatomic Failure (Original Definition) (24 months); Number of Participants With Anatomic Failure (Original Definition) (3 year); Number of Participants With Anatomic Failure (Original Definition) (4 year); Number of Participants With Anatomic Failure (Original Definition) (5 year); Number of Participants With Anatomic Failure (Original Definition) (6 year); Number of Participants With Anatomic Failure (Original Definition) (7 year); Number of Participants With Anatomic Failure (Updated Definition) (24 months); Number of Participants With Anatomic Failure (Updated Definition) (3 year); Number of Participants With Anatomic Failure (Updated Definition) (4 year); Number of Participants With Anatomic Failure (Updated Definition) (5 year); Number of Participants With Anatomic Failure (Updated Definition) (6 year); Number of Participants With Anatomic Failure (Updated Definition) (7 year); Number of Participants With Composite Failure (24 months); Number of Participants With Composite Failure (3 year); Number of Participants With Composite Failure (4 year); Number of Participants With Composite Failure (5 year); Number of Participants With Composite Failure (6 year); Number of Participants With Composite Failure (7 year); Number of Participants Considered as Failures For Urinary Incontinence Using the Incontinence Severity Index (24 months); Number of Participants Considered as Failures For Urinary Incontinence Using the Incontinence Severity Index (3 year); Number of Participants Considered as Failures For Urinary Incontinence Using the Incontinence Severity Index (4 year); Number of Participants Considered as Failures For Urinary Incontinence Using the Incontinence Severity Index (5 year); Number of Participants Considered as Failures For Urinary Incontinence Using the Incontinence Severity Index (6 year); Number of Participants Considered as Failures For Urinary Incontinence Using the Incontinence Severity Index (7 year); Number of Participants With Stress Urinary Incontinence (SUI) Prevention (24 months); Number of Participants With Stress Urinary Incontinence (SUI) Prevention (3 year); Number of Participants With Stress Urinary Incontinence (SUI) Prevention (4 year); Number of Participants With Stress Urinary Incontinence (SUI) Prevention (5 year); Number of Participants With Stress Urinary Incontinence (SUI) Prevention (6 year); Number of Participants With Stress Urinary Incontinence (SUI) Prevention (7 year); Number of Participants With Stress Urinary Incontinence (SUI) (24 months); Number of Participants With Stress Urinary Incontinence (SUI) (3 year); Number of Participants With Stress Urinary Incontinence (SUI) (4 year); Number of Participants With Stress Urinary Incontinence (SUI) (5 year); Number of Participants With Stress Urinary Incontinence (SUI) (6 year); Number of Participants With Stress Urinary Incontinence (SUI) (7 year)
C: Primary outcome: operative time from incision to closure. (Primary outcome: will be obtained immediately at the end of each procedure.)
D: Total Cost of Care Between Standard and Robotic-assisted Laparoscopic Abdominal Sacrocolpopexy (6 Weeks)

Answer: B